April 15, 2004
Superantibodies that can bind to targets within cells, rather than on their surface, could lead to a new range of treatments for diseases, InNexus Biotechnology of Vancouver claims.
Superantibodies could be used to target bacteria and viruses (including HIV) inside cells, for instance, or abnormal proteins that turn cells cancerous. In theory, they could do everything that the small molecules of most conventional drugs do, and more.
The… read more